Immune Response to Influenza Vaccine in Adults With B-cell Malignancies Treated With Idelalisib
Clinical trial NCT03701438 · TERMINATED
Trial details
- NCT number
- NCT03701438
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2018-10-23
- Primary completion
- 2019-10-09
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.